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Abstract
s yk  .The protein tyrosine kinase p72 Syk is expressed in a variety of hematopoietic cell types, including B cells,
thymocytes, mast cells and others. Both the activity and phosphotyrosine content of this enzyme increase in these cells in
response to engagement of the appropriate cell surface receptors. Herein, we describe the cloning of murine Syk and its
expression in Sf9 cells as a catalytically active protein. Full-length Syk and a catalytically active 42.5 kDa carboxyl terminal
fragment were also expressed as glutathione S-transferase fusion proteins. Comparative reverse phase HPLC and 40%
alkaline gel analysis of tryptic digests of phosphorylated Syk demonstrated that all of the major sites of autophosphorylation
were also present in GST-Syk and all but one were contained in the 42.5 kDa fragment. The sites of autophosphorylation
were identified using a combination of Edman sequencing and mass spectrometric analysis. Ten sites were identified. One
 .site is located in the amino terminal half of the molecule between the two tandem Src homology 2 SH2 domains. Five
sites are located in the hinge region located between the carboxyl terminal SH2 domain and the kinase domain. Two sites lie
in the kinase domain within the catalytic loop and two near the extreme carboxyl terminus. Sequences of phosphorylation
sites located within the hinge region predict that Syk serves as a docking site for other SH2 domain-containing proteins.
Consistent with this prediction, autophosphorylated Syk efficiently binds the carboxyl terminal SH2 domain of phospholi-
pase C-g1.
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1. Introduction
 .Protein tyrosine kinase PTKs catalyze the trans-
fer of phosphate from ATP to the hydroxyl groups of
tyrosine residues on substrate proteins. Most PTKs
also catalyze inter- or intramolecular autophospho-
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rylation reactions that lead to their own covalent
modification. These autophosphorylations play im-
portant functional roles. For many cytosolic and
transmembrane PTKs, autophosphorylation of
residues within the active site is required for maximal
w xkinase activity 1–5 . For growth factor receptor ki-
nases, this autophosphorylation-dependent activation
occurs as receptors dimerize after interacting with
w xtheir specific extracellular ligands 6,7 . Autophos-
phorylation also generates binding sites for important
signaling molecules that bind phosphotyrosine
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residues via 100 amino acid stretches known as Src
 . w xHomology 2 SH2 domains 8 . This phenomenon
has been best characterized for the platelet-derived
growth factor receptor where ligation results in the
autophosphorylation of several tyrosine residues that
serve as binding sites for SH2 domain-containing
proteins such as c-Src, phosphatidylinositol 3-kinase
 .  .PI3-Kinase , phospholipase C-g PLC-g , rasGAP,
 . w xprotein tyrosine phosphatase 1D Syp and others 9 .
Many of these proteins subsequently serve as sub-
strates for the activated receptor.
In contrast to growth factor receptors, antigen
receptors on hematopoietic cells lack intrinsic kinase
activity, yet protein-tyrosine phosphorylation plays an
important role in signal transduction through these
receptors. Receptors such as the B cell antigen recep-
 .tor BCR function by virtue of their physical and
functional associations with cytoplasmic, Src- and
non-Src-family PTKs. Aggregation of the BCR re-
sults in a marked increase in the tyrosine phosphory-
lation of several cellular proteins including several
SH2 domain-containing proteins such as PLC-g ,
w x w xPI3-kinase, rasGAP, SHC and others 10 . We 11
w xand others 12,13 have demonstrated that the BCR
s yk  .associates with the cytosolic PTK, p72 Syk .
Both the kinase activity of Syk and its phospho-
tyrosine content increase in response to receptor-
w xmediated B cell activation 12–15 . In Syk-deficient
mice, B cells fail to develop properly, most likely due
w xto defective signaling from the pre-BCR 16 . It is
likely that Syk mediates the coupling of the receptor
to downstream signaling molecules since receptor-
mediated phosphorylation of PLC-g 2 is attenuated in
w xa Syk-deficient avian B cell line 17 and the genera-
tion of IP is blocked in cells treated with a Syk-3
w xselective inhibitor 18 .
The receptor-mediated activation of Syk in B cells
is most likely initiated by the interactions of its two,
tandem, amino terminal SH2 domains with tyrosine-
phosphorylated ITAMs immunoreceptor tyrosine-
.based activation motifs present on the Ig-a and Ig-b
w xcomponents of the BCR complex 19,20 . The bind-
ing of dually phosphorylated ITAM peptides to Syk
in vitro stimulates the enzyme by increasing its au-
w xtophosphorylating activity 21,22 and this is likely to
mirror the in vivo activation process. The conse-
quences of these autophosphorylation events have not
been explored to date, largely because no thorough
study of the sites of Syk autophosphorylation has
been reported. We have, therefore, undertaken to
determine these sites using recombinant murine Syk,
which was cloned and expressed in Sf9 cells. A
combination of Edman sequencing and mass spec-
trometry was used to identify 10 tyrosine residues
that are modified when Syk catalyzes an autophos-
phorylation reaction in vitro. These phosphotyrosines
are localized to sites of the enzyme that are likely to
modulate both its kinase activity and its interactions
with SH2 domain-containing proteins.
2. Materials and methods
2.1. Materials
A random-primed lgt11 cDNA library derived
from the murine pre-B cell line 70rZ was originally
w xprepared by Yinon Ben-Neriah 23 . The baculovirus
transfer vector pNTX was a generous gift of Harry
 .Charbonneau Purdue University . Restriction en-
zymes and DNA modifying enzymes were from
Promega or New England Biolabs. An Oligolabeling
Kit for DNA probe labeling was from Pharmacia
Biotech. Custom oligonucleotides were synthesized
on an Applied Biosystems Model 380B DNA Synthe-
sizer at the Laboratory For Macromolecular Struc-
 .ture, Purdue University. A Sequenase Version 2 kit
from United States Biochemical was used for dideoxy
w 32 x  .DNA sequencing. g- P ATP )6000 Cirmmol
was from NEN Dupont. a- 35S-ATP was from Amer-
 .sham. Baculovirus DNA BacPAK6 was from Clon-
tech. Rabbit polyclonal anti-Syk peptide antibodies
w xhave been described previously 24 .
2.2. Methods
2.2.1. Cloning and expression of murine Syk
A full-length Syk cDNA was prepared from two
overlapping clones isolated from a lgt11, 70rZ pre-B
cell, cDNA library by screening with a 515 bp murine
w xsyk probe 24 . An EcoR I site was engineered by
site-directed mutagenesis 15 nucleotides upstream of
the translational start site, using the Unique Site
w xElimination method 25 , using the following oligo-
nucleotide: 5X-CTTCCCAGAATTCTGAAGGGG-3X.
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The Syk cDNA was inserted into the EcoRIrBamHI
site of the baculovirus expression vector pVL1392
 .Invitrogen . Sf9 cells were cotransfected with pVL-
 . Syk plasmid 2 mg and BacPAK6 viral DNA 1
.mg , and plaque purification was carried out essen-
w xtially as described 26 . Recombinant plaques were
amplified and screened for expression of enzymati-
cally active Syk.
Sf9 cells were infected with high-titer virus at a
multiplicity of infection of 10 for 48 h prior to
harvesting. For the partial purification of Syk, cells
were lysed for 10 min on ice in lysis buffer contain-
ing 1% NP-40, 10 mM Tris-HCl, pH 8.0, 1 mM
Na VO , and a protease inhibitor cocktail of apro-3 4
 .tinin and leupeptin 10 mgrml each , phenylmethyl-
 .sulfonylfluoride and benzamidine 1 mM each and
 .soybean trypsin inhibitor 100 mgrml . The lysate
was spun at 12 000=g for 10 min at 48C. The
supernatant was applied to a column of heparin-
 . agarose Sigma equilibrated in Buffer A 10 mM
Hepes, pH 7.5, 10 mM NaCl, 1 mM Na VO and the3 4
.protease inhibitor cocktail described above . The col-
umn was washed with 20 column volumes of Buffer
A followed by 10 column volumes of Buffer A
containing 200 mM NaCl. Syk was eluted with 2.5
column volumes of Buffer A containing 650 mM
NaCl.
2.2.2. Cloning and expression of GSTp42.5
A 2.4 kb KpnIrBamHI fragment encoding the
42.5 kDa carboxyl terminal fragment amino acids
.256–629 of Syk was subcloned into the KpnIrBglII
site of pNTX, generating pNTXp42.5. This vector is
designed, when introduced into Sf9 cells, to direct the
expression of cDNA inserts as glutathione S-trans-
 .ferase GST fusion proteins. pNTX possesses a
BamHI site just upstream of the translational start site
of a sequence encoding GST. Thus, a 3.1 kb frag-
ment encoding GSTp42.5 was subcloned into
pVL1393, generating the baculovirus transfer vector
pVLGSTp42.5. Sf9 cell co-transfection and plaque
purification were carried out essentially as described
above for full-length Syk. The cloning and expression
w xof GST-Syk is described elsewhere 27 . GSTp42.5
and GST-Syk were isolated from the lysates of vi-
rally infected Sf9 cell lysates by adsorption to glu-
tathione-Sepharose.
2.2.3. Tryptic digestion of autophosphorylated kinase
GST-fusion proteins were phosphorylated while
attached to glutathione-Sepharose in buffer contain-
ing 50 mM Tris-HCl, pH 8.0, 2 mM MnCl , 1 mM2
w 32 x  .Na VO and 50 mM g- P ATP 0.4 mCirnmol at3 4
308C for 30 min. The column was washed with and
resuspended in 50 mM NH HCO , 1 mM Na VO .4 3 3 4
Trypsin, at a protease to substrate ratio of 1:20
 .wrw , was added and the slurry incubated overnight
at 378C with shaking. After a 16 h incubation, the
column was drained and the eluate was saved. The
column was washed with 400 ml aliquots of water
until all radioactivity was eluted. The combined elu-
ates were lyophilized. The resulting pellet was dis-
solved in water and re-lyophilized several times to
remove residual NH HCO . In order to generate4 3
non-radiolabeled tryptic phosphopeptides, a similar
phosphorylation and tryptic digestion was carried out
with only unlabeled ATP in the autophosphorylation
buffer.
Partially purified recombinant Syk was autophos-
phorylated in solution essentially as described above
for the bound GST-fusion proteins, except that the
w 32 xspecific activity of the g- P ATP was 30.0
mCirnmol. Reactions were terminated by the addi-
tion of SDS-sample buffer. Proteins were separated
by SDS-PAGE and transferred to nitrocellulose. 32P-
labeled Syk was detected by autoradiography and
digested on the membrane with trypsin according to
w x28 . Peptides released from the membrane were then
lyophilized.
2.2.4. Re˝erse phase HPLC analysis of tryptic digests
Tryptic digests were solubilized in 0.1% trifluo-
racetic acid and separated by chromatography on a
 .Vydac C-18 column 2.1 mm I.D.=250 mm using
an Applied Biosystems 172A gradient HPLC system.
Peptides were eluted with a linear gradient from 0%
to 30% acetonitrile in 0.1% TFA in 63 min followed
by a linear gradient to 70% acetonitrile in 0.1% TFA
in 10 min at a flow rate of 150 mlrmin. Peptides
were monitored by absorbance at 214 nm and phos-
phopeptides by liquid scintillation spectrometry.
Where necessary, phosphopeptides were rechromato-
graphed using an Applied Biosystems phenyl column
 .2.1 mm I.D.=250 mm using the gradient described
above or a linear gradient from 0% to 60% aceto-
nitrile in 60 min at 200 mlrmin.
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2.2.5. Mass spectrometry of phosphopeptides
Analysis of tryptic peptides by mass spectrometry
was performed using a Vestec Perseptive Biosys-
.tems matrix-assisted laser desorption time-of-flight
 .MALDI-TOF instrument, made available through
the generosity of Dr. Raymond D. Kaiser at Eli Lilly
 .and Company Indianapolis, IN . Biosynthetic Hu-
 q .man Insulin BHI, MH s5809.7 was used as an
internal standard for calibration. All spectra were
collected using 4-hydroxy a-cyano-cinnamic acid as
the matrix. Average masses were calculated using
MacPromass software, a gift from Dr. Terry D. Lee
Beckman Research Institute at the City of Hope,
.Duarte, CA .
2.2.6. Polyacrylamide gel electrophoresis of tryptic
digests
Electrophoretic separation of phosphopeptides was
w xcarried out essentially as described 29 . Briefly, tryp-
tic digests of 32P-labeled Syk or GST-fusion proteins
were resolved on alkaline 40% polyacrylamide gels,
which were then dried onto Whatman 3MM chro-
matography paper. Phosphopeptides were detected by
autoradiography.
2.2.7. PLC-g1 SH2 binding studies
E. coli harboring expression plasmids encoding
GST fusion proteins of bovine PLC-g1 amino and
carboxyl terminal SH2 domains generous gift of
.Tony Pawson, Samuel Lunenfeld Institute, Toronto
were grown overnight in 2X YT medium, diluted
3-fold in fresh medium and induced with isopropylth-
 .iogalactoside 200 mM for 3 h. Cells were lysed and
GST fusion proteins were isolated on glutathione-
w xSepharose beads as described previously 30 . Re-
combinant Syk was autophosphorylated in a 250 ml
reaction essentially as described above, except that
 .BSA 100 mgrml was included in the reaction. The
reaction was terminated on ice with 500 mM EDTA
 .5 ml and 100 ml aliquots of the reaction were added
to 400 ml suspensions of bead-immobilized GST
SH2 fusion proteins ;10 mg protein in 400 ml of
.PBS containing 1% Triton X-100 . The slurries were
rotated at 40C for 1 h. After aspiration of the super-
natant, the beads were washed 3 times with PBSr1%
 .Triton 1 ml , 3 times with PBS, and boiled in
 .SDS-sample buffer 150 ml . Bound proteins were
separated by SDSrPAGE and detected by auto-
radiography.
3. Results
3.1. Molecular cloning of murine syk cDNA
RT-PCR was carried out on total RNA from the
murine B cell line L10.A to generate a 515 bp probe
w x24 , which was used to screen a cDNA library
derived from the murine pre-B cell line 70rZ. Three
 .independent clones 55, 28B and LLA were isolated.
The library inserts, all of which were approx. 3 kb in
length, were subcloned into pBluescript KS 11 and
sequenced. None of the clones contained the com-
plete coding region of murine syk. Clones 55 and
28B were truncated at the 5X-end at codons for Asp
68 and Ala 82, respectively. Clone LLA was trun-
cated at the 3X end at the codon for Asp 606. This
clone was presumably derived from partially spliced
heteronuclear RNA since the sequence immediately
downstream from the truncation point was intronic
Victor Tybulewicz, MRC London, personal commu-
.nication . Full-length murine syk cDNA, deduced
from the three isolated clones, encodes a 629 amino
acid protein with a calculated molecular mass of
 .  .71 330 Da Fig. 1 Genbank Accession a U25685 .
Murine Syk shares )90% amino acid sequence
identity with the previously reported porcine, rat and
w xhuman Syk sequences 15,31,32 .
3.2. Identification of multiple sites of autophospho-
rylation on GST-Syk by HPLC
The engagement of antigen receptors on B cells
leads to a rapid increase in the tyrosine-phosphoryla-
tion of Syk, an event that coincides with changes in
w xthe catalytic activity of the kinase 11–15 and its
interactions with downstream signaling molecules
w x33,34 . Many of these changes occur in the absence
of exogenous tyrosine kinases, indicating that the
autophosphorylating activity of Syk is critical to its
w xfunction 35 . We set out, therefore, to identify those
tyrosine residues on Syk that are covalently modified
following its incubation with ATP.
To obtain sufficient, purified enzyme for this anal-
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Fig. 1. Amino acid sequence of murine Syk. The amino acid
sequence of full-length murine Syk was deduced from clones 55
and LLA, which were isolated and sequenced as described in
Section 2. The bounderies of the two SH2 domains and the
kinase domain are indicated by brackets.
ysis, Syk was expressed in Sf9 cells as a fusion
 .protein coupled to GST GST-Syk . A full-length Syk
cDNA was constructed from two of the partial clones
 .55 and LLA and inserted into a vector containing
the coding sequence for GST. GST-Syk, after partial
purification by immobilization on glutathione-Sep-
harose beads, efficiently catalyzed an autophospho-
w 32 xrylation reaction when incubated with g- P ATP
 .Fig. 2 .
To begin an analysis of the sites modified during
autophosphorylation, purified, autophosphorylated
GST-Syk was extensively digested with trypsin.
Tryptic peptides were separated by reverse phase
HPLC on a C-18 column. Peptides were collected by
O.D. and crude phosphopeptides were identified214
by scintillation counting. Analysis of the resulting
profile, shown in Fig. 3A, indicated that the auto-
phosphorylation of GST-Syk in vitro led to the cova-
lent modification of numerous sites.
3.3. Autophosphorylation of GSTp42.5
The amino terminal half of Syk contains two SH2
domains that govern the interactions of the kinase
with ITAMs on antigen receptors while the carboxyl
terminal half contains the catalytic domain. These
functional domains are separated by a ‘hinge’ region
w xthat is highly susceptible to proteolysis 31,36 . To
 .identify the domain s containing the major sites of
autophosphorylation, a 42.5 kDa carboxyl terminal
fragment of murine Syk, which lacks the tandem SH2
domains, was expressed in Sf9 cells as a GST-fusion
 .protein GSTp42.5 . As shown in Fig. 2, GSTp42.5,
isolated from insect cell lysates by adsorption to
glutathione-Sepharose, was also active as a kinase
and readily catalyzed an autophosphorylation reaction
w 32 xwhen incubated with g- P ATP.
GSTp42.5 was autophosphorylated and digested
with trypsin in an identical manner to GST-Syk. The
 .HPLC C-18 profile of the resulting phosphopep-
tides was essentially identical to that of GST-Syk
 . Fig. 3B except for the absence of peptide 1 Fig.
.3A . Also in this chromatogram, peak 6 was clearly
resolved into three separate peaks.
3.4. Identification of phosphopeptides deri˝ed from
GSTp42.5 and GST-Syk
Electrophoresis of a small aliquot of Peak 6 on a
w x40% polyacrylamide alkaline gel 29 followed by
Fig. 2. In vitro autophosphorylation of recombinant GST-kinase
 .  .fusion proteins. GST-Syk lane 1 and GSTp42.5 lane 2 , iso-
lated from Sf9 cells by adsorption to glutathione-Sepharose, were
w 32 xautophosphorylated in the presence of g- P ATP, separated by
SDS-PAGE and detected by autoradiography. The migration
positions of mol. wt. standards are indicated in kDa.
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Fig. 3. Separation of tryptic phosphopeptides from in vitro au-
 .tophosphorylated GST-Syk and GSTp42.5. GST-Syk A or
 . wGSTp42.5 B were autophosphorylated in the presence of g-
32 xP ATP and digested with trypsin as described in Section 2.
Tryptic peptides were then separated by reverse phase HPLC on
a C-18 column. Peptides were collected by absorbance at 214 nm
and phosphopeptides were detected by Cherenkov counting.
 .autoradiography of the separated peptides Fig. 4A
confirmed the presence of three distinct phosphopep-
 .tides 6a, 6b and 6c . Crude GSTp42.5 tryptic phos-
phopeptides corresponding to peaks 6a, 6b and 6c
derived from the C-18 column were further purified
 .on a phenyl column Fig. 5 . Each peak contained a
single, major phosphopeptide. These were collected
and subjected to Edman sequence analysis. Partial
sequence analysis of peaks 6a and 6c gave identical
 .results Table 1 , even though they were well sepa-
rated on HPLC. This anomaly was resolved by sub-
jecting these two peptides to MALDI-TOF mass
 .spectrometry Fig. 6 . The observed ions for peptides
 q6a and 6c MH s2842.08 and 2760.94 amu, respec-
.tively , were in close agreement with the predicted
molecular masses of the di- and monophosphorylated
forms of the hinge region-derived tryptic peptide
encompassing amino acids 333–355 calculated
q .MH s2840.95 and 2760.95 amu, respectively . In
 .order to determine which tyrosine residue s in the
monophosphopeptide was modified, peptide 6c was
 .re-subjected to Edman sequencing 20 cycles . Tyro-
sine was observed at cycle 10, but not at cycle 14,
suggesting that this peptide was phosphorylated ex-
clusively on Tyr 346.
 .Partial sequence analysis 10 cycles of peptide 6b
indicated that this was another hinge region-derived
tryptic peptide, corresponding to amino acids 299–
 .  .328 Table 1 . Mass spectrometric analysis Fig. 6
 q .produced a molecular ion MH s3289.95 , that was
 .consistent with the phosphorylated Tyr 317 peptide
 q .calculated MH s3290.49 .
GSTp42.5 phosphopeptides corresponding to peak
5 were further purified by phenyl column HPLC Fig.
.7 . Peak 5 generated 3 major phosphopeptide-contain-
ing peaks. Analysis of each peak by 40% polyacryl-
amide alkaline gel electrophoresis indicated that peaks
eluting at 17 and 21.5 min each contained a single
 .phosphopeptide 5a and 5b, respectively while the
peak eluting at 22.5 min contained two different
 .  .phosphopeptides 5c and 5d Fig. 4B . Edman se-
Fig. 4. Separation of phosphopeptides by electrophoresis on 40%
polyacrylamide alkaline gels. Aliquots of peaks derived from the
HPLC separation of various phosphopeptides were evaporated to
dryness, dissolved in sample buffer and separated on 40% alka-
line gels as described in Section 2. Phosphopeptides were de-
 .tected by autoradiography. Peptides 6a–6c A were derived from
peak 6, Fig. 3A, and are labeled in the order in which they elute
 .from a phenyl HPLC column. Peptides 5a–5d B are derived
 .from phenyl column HPLC separation of peak 5 Fig. 7 and are
 .labeled in the order in which they eluted. Peptides 2–4 C and
 . peptide 1 D are derived from the corresponding peaks Fig.
.3A .
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Table 1
Sequences of tryptic phosphopeptides derived from autophosphorylated Syk
a bPeptide Residues Phosphotyrosine Sequence
1 129–132 130 EpYVK
2 515–521 519r520 ADENpYpYK
3 515–527 519r520 ADENpYpYKAQTHGK
4a 515–521 520 ADENYpYK
4b 515–521 519 ADENpYYK
5a 356–361 358 EVpYLDR
5b 289–298 290 SpYSFPKPGHK
5c 620–629 623r624r625 LRNYpYpYDVVN
5d 622–629 623r624r625 NYpYpYDVVN
6a 333–355 342r346 EALPMDTEVpYESPpYADPEEIRPK
6b 299–328 317 KPAPPQGSRPESTVSFNPpYEPTGGPWGPDR
6c 333–355 346 EALPMDTEVYESPpYADPEEIRPK
a  .Peptides were purified by phenyl column HPLC of the C-18 column HPLC peaks 1-6 Fig. 3 and characterized as described in Section
2.
b Phosphorylated tyrosine residues are denoted as pY.
quence analyses indicated that peptides 5a and 5b
corresponded to amino acids 356–361 and 289–298,
 .respectively Table 1 . The absence of tyrosine at the
appropriate sequencing cycles confirmed that Tyr 358
and Tyr 290, respectively, were phosphorylated in
these two peptides. Sequence analysis of the peak
eluting at 22.5 min confirmed the presence of two
phosphopeptides. These phosphopeptides, 5c and 5d,
were related by incomplete proteolysis, and corre-
sponded to amino acids 620–629 and 622–629, re-
spectively. Mass spectrometric analysis of peptide 5c
 q .produced a molecular ion MH s1480.3 that was
consistent with that of a doubly phosphorylated pep-
 q .  .tide calculated MH s1479.5 Fig. 8A . Edman
sequencing analysis of peptide 5d yielded tyrosine
only in cycle two, suggesting that Tyr 624 and 625
were the principal sites of phosphorylation.
Peaks 2, 3 and 4 from GSTp42.5 all corresponded
to peptides that contained tyrosines 519r520 Table
.1 . Peaks 2 and 3 each contained a single phospho-
peptide as analyzed by 40% polyacrylamide alkaline
 .gel electrophoresis Fig. 4C and by phenyl column
 .HPLC Fig. 9A and B . As determined by Edman
sequencing, these peptides corresponded to amino
acids 515–521 and 515–527, respectively, with pep-
tide 3 corresponding to an incompletely proteolyzed
form of peptide 2. These peptides were phosphory-
lated on both tyrosine residues, as evidenced by the
absence of detectable tyrosine at cycles 5 and 6 in
both sequences. Mass spectrometric analysis of pep-
Fig. 5. Separation of phosphopeptides 6a, 6b and 6c by phenyl
 .column HPLC. Peak fractions corresponding to peaks 6a A , 6b
 .  .B and 6c C of Fig. 3B were separately chromatographed on a
phenyl column. Peptides were detected by absorbance at 214 nm
 .  .solid line and by scintillation spectrometry dashed line .
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 .Fig. 6. Mass spectra of peptides 6a, 6b and 6c. Peptides 6a, 6b and 6c shown in Fig. 5 were characterized by mass spectrometry as
 .  .described in Section 2. The minor peaks near 2905 MrZ correspond to the doubly protonated internal standard BHI .
 q .tide 3 yielded a molecular ion MH s1686.7 con-
sistent with that of the doubly phosphorylated peptide
 q .  .calculated MH s1685.7 Fig. 8B .
Peak 4 yielded a single phosphopeptide by 40%
 .polyacrylamide alkaline gel electrophoresis Fig. 4C ,
 .but gave rise to two phosphopeptides 4a and 4b
following chromatography on the phenyl column Fig.
.9C and D . By Edman sequencing, these peptides
were identified as monophosphorylated forms of pep-
tide 2, and were distinguishable by the absence of
Fig. 7. Separation of peak 5 phosphopeptides by phenyl column
HPLC. Peak fractions corresponding to peak 5 of Fig. 3B were
chromatographed on a phenyl column. Peptides were detected by
 .absorbance at 214 nm solid line and by scintillation spectrome-
 .try dashed line .
detectable tyrosine at either cycle 6 or 5 of their
respective sequences.
As mentioned above, tryptic digestion of GST-Syk
produced an essentially identical HPLC C-18 col-
.umn profile to that derived from GSTp42.5, with the
exception of an additional, early eluting phosphopep-
 .tide peptide 1 in Fig. 3A . Analysis by 40% poly-
acrylamide alkaline gel electrophoresis indicated the
presence of a single phosphopeptide in peak 1 Fig.
 .Fig. 8. Mass spectra of peptides 5c and 3. Peptides 5c Fig. 7
 .  .  .A and 3 Fig. 9 B were characterized by mass spectrometry
as described in Section 2.
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 .  .Fig. 9. Separation of phosphopeptides 2, 3 and 4 by phenyl column HPLC. Peak fractions corresponding to peaks 2 A , 3 B and the
 .  .  .left- C and right-hand D sides of peak 4 C and D of Fig. 3B were separately chromatographed on a phenyl column. Peptides were
 .  .detected by absorbance at 214 nm solid line and by scintillation spectrometry dashed line .
.4D . This peptide was purified by HPLC on a phenyl
 .column data not shown and identified by Edman
sequencing as corresponding to amino acids 129–132,
which lie between the two SH2 domains of Syk. The
absence of detectable tyrosine at cycle 2 was consis-
tent with the presence of phosphotyrosine at residue
130. This phosphopeptide was missing from tryptic
digests of an autophosphorylated, mutant form of Syk
in which Tyr 130 had been mutated to Phe Keshvara,
.L. and Geahlen, R.L. unpublished data .
3.5. Autophosphorylation of recombinant Syk
To determine which of the autophosphorylation
sites from the GST-Syk were present in autophospho-
rylated Syk, partially purified recombinant Syk was
phosphorylated, separated by SDS-PAGE and trans-
ferred to nitrocellulose. Syk was the only phosphory-
 .lated protein detected by autoradiography Fig. 10A .
Tryptic digestion of Syk off of the membrane pro-
duced a series of peptides whose C-18 HPLC profile
 .was similar to that of GST-Syk data not shown .
Syk-derived radiolabeled peptides eluting at similar
times to those derived from the GST fusion proteins
were compared to the latter by separation on 40%
alkaline gel electrophoresis followed by autoradiog-
raphy. A representative autoradiogram, demonstrating
the presence of peptides 6a, 6b and 6c in autophos-
phorylated Syk, is shown in Fig. 10B. These compar-
isons demonstrated that all 10 of the phosphotyrosine
residues present in autophosphorylated GST-Syk were
present in the recombinant enzyme. Thus, the pres-
ence of the GST moiety on GST-Syk did not generate
any new autophosphorylation sites not found on the
wild-type enzyme.
 .Fig. 10. Sites of autophosphorylation in recombinant Syk. A In
vitro autophosphorylation of recombinant Syk. Partially purified
recombinant Syk was autophosphorylated in the presence of
w 32 xg- P ATP as described in Section 2. Proteins were separated by
SDS-PAGE and phosphorylated Syk was detected by autoradiog-
raphy. The migration positions of molecular weight standards are
 .indicated in kDa. B 40% polyacrylamide alkaline gel compari-
son of peptides 6a, 6b and 6c from GSTp42.5 and recombinant
Syk. HPLC-purified phosphopeptides 6b, 6a and 6c, generated by
tryptic digestion of autophosphorylated GSTp42.5 lanes 1, 3 and
.  .5 and Syk lanes 2, 4 and 6 were separated by 40% polyacryl-
amide alkaline gel electrophoresis as described in Section 2.
Peptides were detected by autoradiography.
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Fig. 11. Interaction of Autophosphorylated recombinant Syk with
SH2 domains of PLC-g1. Recombinant Syk was autophosphory-
w 32 xlated in the presence of g- P ATP and incubated with glu-
tathione-Sepharose-immobilized GST fusion proteins of either
 .  .the amino lane 1 or carboxyl lane 2 terminal SH2 domains of
bovine PLC-g1 as described in Section 2. After washing of the
beads, bound Syk was separated by SDS-PAGE and detected by
autoradiography.
3.6. Analysis of interaction between autophosphory-
lated recombinant Syk and SH2 domains of PLC-g1
Phosphorylated tyrosine residues often mediate
w xprotein binding to SH2 domains of other proteins 8 .
Three of the Syk autophosphorylation sites deter-
 .mined above Tyr 290, 342 and 346 are each part of
 .a PO Tyr X X Pro motif, which suggests that they4
may form binding sites for the carboxyl terminal SH2
w xdomain of PLC-g1 38 . Given the recent report of
the association with Syk with PLC-g1 in lysates of
w xactivated B cells 33 , we investigated the in vitro
association of autophosphorylated recombinant Syk
with each SH2 domain of this signaling protein. Syk
wwas autophosphorylated in the presence of g-
32 xP ATP and incubated with immobilized GST fusion
proteins of PLC-g1 amino and carboxyl terminal
Fig. 12. Relative locations of autophosphorylation sites in murine
Syk.
SH2 domains. Syk-PLC-g1 SH2 domain interactions
 .were detected by autoradiography Fig. 11 . Radiola-
beled Syk bound preferentially to the PLC-g1 car-
boxyl terminal SH2 fusion protein.
4. Discussion
The Syk protein-tyrosine kinase becomes tyrosine
phosphorylated and activated in response to the ag-
gregation of immune recognition receptors on a vari-
ety of hematopoietic cell types. The clustering of
these antigen receptors initiates a cascade of bio-
chemical events beginning with the increased phos-
phorylation of proteins such as PLC-g on tyrosine.
These, in turn, couple receptor engagement to in-
creases in the levels of intracellular second messen-
gers such as calcium and inositol 1,4,5-trisphosphate
 .IP . These responses are generally blocked in cells3
in which Syk has been either deleted or inhibited,
indicating that Syk is a critical component of this
w xsignaling machinery 16–18 . The binding of Syk to
clustered, phosphorylated ITAMs induces its phos-
w xphorylation and activation 39 . The kinase or kinases
that catalyze the phosphorylation of Syk likely in-
clude Syk itself as well as members of the Src-family
w xof protein-tyrosine kinases 40 . In mast cells and T
cells, clustering of a chimeric receptor containing the
extracellular domain of CD16 and Syk as a cytoplas-
mic domain is sufficient to reproduce the full spec-
trum of signals generated by aggregation of each
respective receptor i.e., T cell antigen receptor or
. w xFce RI 35,41 . It is likely, therefore, that Syk itself
is capable of catalyzing the bulk of the phosphoryla-
tion reactions that are important to its activation and
subsequent involvement in cell signaling pathways.
To begin to understand how the autophosphorylation
of Syk might be involved in signaling, we initiated a
study to map the major sites of autophosphorylation.
Our analysis of autophosphorylation sites indicate
that at least ten different tyrosine residues can be
covalently modified following the incubation of Syk
w 32 x  .with g- P ATP Table 1 . The relative locations of
these sites are indicated on the model shown in Fig.
12. The first site, beginning from the amino terminus,
is Tyr-130. Tyr-130 is present in a short tryptic
peptide, EYVK, that is located between the two
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tandem SH2 domains that make up the amino termi-
nal half of Syk. Tyr-130 and the amino acids sur-
rounding it are highly conserved in Syk cDNAs
cloned from murine, rat, porcine and human species
 w x.Fig. 1; 15,31,32,42 , suggesting that this region
may play an important functional role. Tyr-130 is
also analogous to Tyr-126 of the Syk-related kinase,
ZAP-70, which is found within the related sequence,
w xDYVR 43 . Tyr-126 has previously been identified
as a site of autophosphorylation in recombinant ZAP-
w x70 44 . The consequences of phosphorylation at
Tyr-130 are uncertain, but its presence between the
tandem SH2 domains suggests that it could play a
role in modulating the interactions of Syk with the
ITAMs present on receptor components. Following
receptor engagement, Syk associates with phosphory-
lated ITAMs on clustered receptors, but is released
following tyrosine phosphorylation and activation
w x27 . The phosphorylation of Tyr-130 could conceiv-
ably play a role in the release of the activated kinase.
Alternatively, phosphorylation at this site may modu-
late the interactions of Syk or ZAP-70 with other
proteins.
Five sites of autophosphorylation lie within a hinge
or spacer region that separates the SH2 domains from
the carboxyl terminal catalytic domain. In Syk, this
hinge is likely to be exposed since the enzyme is very
sensitive to proteolytic cleavage within this region
w x31,36 . Proteolysis yields an active carboxyl termi-
nal, catalytic fragment of approximately 40 kDa; and
it was this 40 kDa form of Syk that was first isolated
w xfrom bovine thymus and porcine spleen 45,46 . The
first site in the hinge region, Tyr-290, is present in a
23 amino acid insert that is missing from ZAP-70 and
from a shorter, alternatively spliced variant of Syk
w x42 . It is, however, highly conserved in the most
abundant form of Syk from all species that have been
examined. The second site, Tyr-317, is also con-
served in all Syk species, but amino acid residues
distal to this site are somewhat variable. This tyrosine
is localized to a region analogous to that of Tyr-292,
an autophosphorylation site identified in the spacer
w xregion of ZAP-70 44 . The sequence surrounding
 .Tyr-317 PYEPT is also similar to that found in
 .ZAP-70 YTPEP .
The peptide containing the third and fourth sites,
Tyr-342 and Tyr-346, was isolated in both mono- and
di-phosphorylated forms Table 1 - peptides 6c and
.6a, respectively . The monophosphorylated peptide
 .6c contained phosphotyrosine only at position 346,
suggesting that phosphorylation of Tyr-342 and Tyr-
346 occurs in an ordered fashion. The amino acids
surrounding these tyrosines are completely conserved
in all forms of Syk and are highly similar to an
analogous region found in ZAP-70. In general, the
spacer regions of Syk and ZAP-70 show little se-
quence similarity with the exception of a 16 amino
w xacid stretch that surrounds these tyrosines 42 . These
analogous tyrosines have not been identified as sites
w xof autophosphorylation in ZAP-70 44 . They are,
however, rapidly phosphorylated in Syk, even with
low concentrations of ATP and short incubation times
 .unpublished observations . The fifth site, Tyr-358, is
completely conserved among all Syk sequences re-
ported to date, but lies within a region that bears no
w xsequence similarity to ZAP-70 42 .
Since the five sites of autophosphorylation in the
spacer lie within the exposed hinge region, it is
attractive to speculate that they mediate protein-pro-
tein interactions. Ligand-induced autophosphorylation
of receptor PTKs generates phosphotyrosine-based
motifs that bind SH2 domains of various downstream
signaling proteins, including PLC-g , PI3-kinase and
w xmany others 8 . Syk and ZAP-70 may act in a
similar fashion. ZAP-70, when bound to phosphory-
lated ITAMs, becomes phosphorylated on multiple
tyrosines and gains the ability to bind the SH2 do-
w xmains of Fyn, Lck, Abl and rasGAP 47 . ZAP-70
has also been reported to interact directly with Vav in
w xan interaction mediated by the Vav SH2 domain 48 .
Syk, in turn, has been shown to physically associate
w xwith PLC-g1 33 and with the Src-family kinases
w xLyn and Blk through their SH2 domains 34 . Using a
phosphopeptide library affinity selection technique,
Cantley and co-workers have determined that the
affinity of a given SH2 domain for an interacting
protein is governed principally by the identity of the
three amino acids that reside immediately carboxyl
terminal to the interacting phosphotyrosine residue of
w xthat protein 38,49 . For example, these studies pre-
dict that the amino and carboxyl terminal SH2 do-
mains of PLC-g1 should bind preferentially to
 .  .PO Tyr-Leu-GlurAsp-Leu and PO Tyr-ValrIle-4 4
w xX-Pro, respectively 38 . The predicted binding pref-
erence of the carboxyl terminal SH2 domain of PLC-
g1 corresponds most closely to three phospho-
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tyrosine-containing motifs present in the hinge region
 .of autophosphorylated Syk: PO Tyr-290-Ser-Phe-4
 .  .Pro, PO Tyr-342-Glu-Ser-Pro and PO Tyr-346-4 4
Ala-Asp-Pro. This specificity is consistent with the
observation that the carboxyl terminal, but not the
amino terminal SH2 domain of PLC-g1 efficiently
 .binds autophosphorylated Syk in vitro Fig. 11 .
Within the cell, such an interaction could facilitate
the binding and tyrosine phosphorylation of PLC-g1
by Syk. The tyrosine phosphorylation of PLC-g1 on
Tyr 783 and Tyr 1254 has been implicated in its
w xactivation in B cells, T cells and fibroblasts 50–52 ,
and Syk has been shown to phosphorylate peptides
that correspond to regions of PLC-g1 known to be
w xphosphorylated in lymphocytes 53 . In fact, a recent
study indicates that PLC-g1 does, indeed, interact
with phosphotyrosine residues present within the
w xhinge region and serves as a substrate for Syk 54 .
Two sites of Syk autophosphorylation Tyr-519
.and Tyr-520 are located within the catalytic domain.
These residues had been identified as autophospho-
w xrylation sites in a previous report 37 . Analogous
sites of autophosphorylation are found in activation
loops present in the catalytic domains of most pro-
tein-tyrosine kinases and their phosphorylation plays
a positive role in activation. As shown for Tyr-1162
of the insulin receptor, the unphosphorylated tyrosine
is bound in the active site where it precludes the
w xbinding of ATP 55 . The phosphorylation of Tyr-
1162 then relieves this inhibition and the kinase is
now active. In ZAP-70, Tyr-493 appears to be most
analogous to the insulin receptor Tyr-1162. A Tyr-493
to Phe-493 mutant of ZAP-70 exhibits low basal
activity and is no longer activated by tyrosine phos-
w xphorylation 5 . Interestingly, an adjacent residue,
Tyr-492, when mutated to Phe, results in a constitu-
w xtively active form of ZAP-70 5 . Its exact role in
regulating the activity of the kinase has yet to be
determined.
Tyrosines 519 and 520 of Syk are analogous to
tyrosines 492 and 493 of ZAP-70. Both singly and
dually phosphorylated forms of the peptide contain-
ing residues 519 and 520 were isolated. The presence
of two phosphates on the peptide inhibited proteoly-
sis at Lys-521 leading to the recovery of a phospho-
peptide that was six amino acids longer than the
expected one. Singly phosphorylated forms of the
peptide were efficiently cleaved at Lys-521 and both
of the possible monophosphorylated peptides were
recovered. This suggests that the phosphorylation of
these tyrosines are not likely to occur in a specific
order.
It is interesting to note that ZAP-70 does not
catalyze the autophosphorylation of tyrosines 492 and
493, but that these sites can be phosphorylated by
w xSrc-family kinases such as Lck 44 . In JCam.1 T-
cells, which lack active Lck, engagement of the T
cell antigen receptor fails to activate ZAP-70 and
fails to generate a biochemical signal, indicating that
phosphorylation by Lck is a likely prerequisite for
w xactivation 56 . The ability of Syk, but not ZAP-70,
to catalyze these autophosphorylations may explain
some of the functional differences between these
kinases. For example, while the CD16rSyk chimeric
receptors described above can signal effectively in
w xtransfected T cells 35 , the corresponding
CD16rZAP-70 chimeras do not, unless they are co-
crosslinked with chimeras bearing a Src-family ki-
nase such as Fyn as a cytoplasmic domain. Thus,
ZAP-70 is dependent on a Src-family kinase for
phosphorylation of the tyrosines present on the acti-
vating loop while Syk appears to have the capacity to
autoactivate.
The final two sites, tyrosines 624 and 625 are
located in the extreme carboxyl terminus of Syk.
Tyrosines 623, 624 and 625 are completely conserved
in all forms of Syk. These three tyrosines are also
found in murine ZAP-70; two of the three are found
in the human homolog. ZAP-70 has a 17 amino acid
carboxyl terminal extension that is lacking in Syk. In
all Src-family kinases, a tyrosine located near the
carboxyl terminus plays an important role in regulat-
w xing enzyme activity 1 . Phosphorylation of this site
by the Csk protein-tyrosine kinase negatively regu-
w xlates the activity of the Src-kinases 57 . It is not yet
known if the carboxyl terminal tyrosines play a simi-
lar role in regulating the activities of the Syk-family
enzymes. An antibody directed against the carboxyl
terminus of Syk can block its activation in solution
by phosphorylated ITAM peptides, suggesting that
this region of the molecule may, in fact, play a role in
w xenzyme regulation 21 . This role could conceivably
involve the phosphorylation of one or more tyrosines
present in this region.
In summary, we have determined the sites of in
vitro autophosphorylation of the hematopoietic PTK
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Syk and provided evidence for a docking function for
at least one of these sites. In order to ascribe physio-
logical significance to any of these in vitro sites, their
occurrence in unactivated andror activated hemato-
poietic cell types must first be demonstrated. The
specific functional significance of each site must also
await studies on site-directed mutants of Syk. Efforts
are underway to determine the in vivo sites of Syk
phosphorylation and their roles in signal transduction.
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